Logo image of SFT

SHIFT TECHNOLOGIES INC (SFT) Stock Fundamental Analysis

NASDAQ:SFT - Nasdaq - US82452T3059 - Common Stock - Currency: USD

0.1703  +0.06 (+58.12%)

After market: 0.13 -0.04 (-23.66%)

Fundamental Rating

2

Taking everything into account, SFT scores 2 out of 10 in our fundamental rating. SFT was compared to 120 industry peers in the Specialty Retail industry. SFT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, SFT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

SFT had negative earnings in the past year.
SFT had a negative operating cash flow in the past year.
In the past 5 years SFT always reported negative net income.
SFT had a negative operating cash flow in each of the past 5 years.
SFT Yearly Net Income VS EBIT VS OCF VS FCFSFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -50M -100M -150M -200M

1.2 Ratios

SFT has a Return On Assets of -124.16%. This is amonst the worse of the industry: SFT underperforms 95.45% of its industry peers.
Industry RankSector Rank
ROA -124.16%
ROE N/A
ROIC N/A
ROA(3y)-44.59%
ROA(5y)-52.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SFT Yearly ROA, ROE, ROICSFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 100 -100 200 -200

1.3 Margins

SFT's Gross Margin of 2.74% is on the low side compared to the rest of the industry. SFT is outperformed by 93.94% of its industry peers.
In the last couple of years the Gross Margin of SFT has declined.
The Profit Margin and Operating Margin are not available for SFT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-4.56%
SFT Yearly Profit, Operating, Gross MarginsSFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -10 -20 -30 -40

1

2. Health

2.1 Basic Checks

SFT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SFT has more shares outstanding than it did 1 year ago.
SFT has a worse debt/assets ratio than last year.
SFT Yearly Shares OutstandingSFT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M 15M
SFT Yearly Total Debt VS Total AssetsSFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -10.35, we must say that SFT is in the distress zone and has some risk of bankruptcy.
SFT has a worse Altman-Z score (-10.35) than 96.21% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.35
ROIC/WACCN/A
WACC4.06%
SFT Yearly LT Debt VS Equity VS FCFSFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 1.32 indicates that SFT should not have too much problems paying its short term obligations.
SFT has a worse Current ratio (1.32) than 60.61% of its industry peers.
SFT has a Quick Ratio of 1.32. This is a bad value and indicates that SFT is not financially healthy enough and could expect problems in meeting its short term obligations.
SFT has a Quick ratio of 0.92. This is in the better half of the industry: SFT outperforms 67.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.92
SFT Yearly Current Assets VS Current LiabilitesSFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 100M 200M 300M

6

3. Growth

3.1 Past

SFT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.10%, which is quite good.
Looking at the last year, SFT shows a very negative growth in Revenue. The Revenue has decreased by -59.86% in the last year.
Measured over the past years, SFT shows a very strong growth in Revenue. The Revenue has been growing by 47.99% on average per year.
EPS 1Y (TTM)18.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.81%
Revenue 1Y (TTM)-59.86%
Revenue growth 3Y59.22%
Revenue growth 5Y47.99%
Sales Q2Q%-78.86%

3.2 Future

Based on estimates for the next years, SFT will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.91% on average per year.
The Revenue is expected to grow by 43.15% on average over the next years. This is a very strong growth
EPS Next Y86.26%
EPS Next 2Y40.11%
EPS Next 3Y25.64%
EPS Next 5Y14.91%
Revenue Next Year-72.52%
Revenue Next 2Y-45.56%
Revenue Next 3Y-18.29%
Revenue Next 5Y43.15%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SFT Yearly Revenue VS EstimatesSFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
SFT Yearly EPS VS EstimatesSFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -5 -10 -15 -20 -25

1

4. Valuation

4.1 Price/Earnings Ratio

SFT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SFT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SFT Price Earnings VS Forward Price EarningsSFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SFT Per share dataSFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as SFT's earnings are expected to grow with 25.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.11%
EPS Next 3Y25.64%

0

5. Dividend

5.1 Amount

SFT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SHIFT TECHNOLOGIES INC

NASDAQ:SFT (10/18/2023, 9:51:01 PM)

After market: 0.13 -0.04 (-23.66%)

0.1703

+0.06 (+58.12%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-10 2023-08-10/amc
Earnings (Next)11-06 2023-11-06/amc
Inst Owners0%
Inst Owner Change-85.86%
Ins Owners153.7%
Ins Owner Change0%
Market Cap2.90M
Analysts44.44
Price Target2.45 (1338.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.16%
Min EPS beat(2)-0.59%
Max EPS beat(2)34.91%
EPS beat(4)2
Avg EPS beat(4)-12.85%
Min EPS beat(4)-107.02%
Max EPS beat(4)34.91%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.29%
Min Revenue beat(2)-20.96%
Max Revenue beat(2)-5.61%
Revenue beat(4)1
Avg Revenue beat(4)-6.53%
Min Revenue beat(4)-20.96%
Max Revenue beat(4)11.7%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)79.2%
EPS NY rev (1m)0%
EPS NY rev (3m)61.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-42.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-31.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-17.1
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-5.11
FCFYN/A
OCF(TTM)-4.5
OCFYN/A
SpS19.35
BVpS-7.69
TBVpS-8.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -124.16%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.74%
FCFM N/A
ROA(3y)-44.59%
ROA(5y)-52.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-4.56%
F-Score3
Asset Turnover2.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 77.2%
Cap/Sales 3.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.92
Altman-Z -10.35
F-Score3
WACC4.06%
ROIC/WACCN/A
Cap/Depr(3y)153.74%
Cap/Depr(5y)163.52%
Cap/Sales(3y)2.32%
Cap/Sales(5y)2.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.81%
EPS Next Y86.26%
EPS Next 2Y40.11%
EPS Next 3Y25.64%
EPS Next 5Y14.91%
Revenue 1Y (TTM)-59.86%
Revenue growth 3Y59.22%
Revenue growth 5Y47.99%
Sales Q2Q%-78.86%
Revenue Next Year-72.52%
Revenue Next 2Y-45.56%
Revenue Next 3Y-18.29%
Revenue Next 5Y43.15%
EBIT growth 1Y20.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.69%
EBIT Next 3Y20.54%
EBIT Next 5Y15.54%
FCF growth 1Y60.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.96%
OCF growth 3YN/A
OCF growth 5YN/A